ARTICANZ - Beta (ver 0.91)

Annotated Registry of Trials in Cancer, Australia and New Zealand Ed. - Results - target/anti-TIGIT-monoclonal-antibody

Search results

target/anti-TIGIT-monoclonal-antibody
6 trial(s) found.
NCT05277051
NCT04929223
NCT04524871
NCT04164199
NCT02861573
NCT05805501
Filters
PD-1/PD-L1
100%
TIGIT
100%
PD-1
83%
VEGF
67%
LAG3
50%
PD-L1
33%
HIF2a
33%
KIT
33%
PARP
33%
PDGFR
33%
VEGFR
33%
B7H3
17%
PVRIG
17%
CDK7
17%
EGFR
17%
KRAS
17%
KRAS G12C
17%
PI3Kalpha
17%
CTLA4
17%
IL-6
17%
PPAR-alpha
17%
ERBB2
17%
HPK1
17%
OX40
17%
RET
17%
TIM3
17%
VEGFR1
17%
VEGFR2
17%
VEGFR3
17%
AR
17%
CYP17A1
17%
androgen axis
17%




















 






























	
		
	

    

        

			ARTICANZ (Annotated Registry of Trials in Cancer, Australia/NZ Edition; ARTificial Intelligence-enhanced CANcer trial information database) provides information about cancer drug trials in Australia and New Zealand as a free, open-information platform. Please note the following:

			
    
			
  • Data Accuracy: While ARTICANZ strives to maintain accurate and up-to-date information through regular weekly updates and specialist review, we cannot guarantee the complete accuracy, reliability, or timeliness of all data. Information may change between updates.
    • 
			
			
  • Not Medical Advice: The information provided by ARTICANZ is for informational purposes only and should not be considered medical advice. All clinical decisions should be made in consultation with qualified healthcare professionals.
    • 
			
			
  • No Warranty: ARTICANZ is provided "as is" without any warranties, expressed or implied. We disclaim all liability for any damages arising from the use of or inability to use this platform.
    • 
			
			
  • External Links: ARTICANZ may contain links to external websites. We are not responsible for the content or privacy practices of these sites.
    • 
			
			


			By using ARTICANZ, you acknowledge that you have read and understood this disclaimer.
			
		

        

            
The ARTICANZ platform and its contents are made available under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

            
            
Users are free to:

            
    
                
  • Share — copy and redistribute the data in any medium or format
    • 
                
  • Adapt — remix, transform, and build upon the data
    • 
                
  • Use the data for any purpose, including commercial use
    • 
            

            
            
Under the following terms:

            
    
                
  • Attribution — You must give appropriate credit to ARTICANZ, provide a link to the license, and indicate if changes were made
    • 
                
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
    • 
            

            
            
Platform developed and currently maintained by Dr. Frank Lin and the ARTICANZ team.